Christopher R. Flowers, MD

Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX

Martin Dreyling, MD¹, Jeanette K. Doorduijn, MD, PhD², Eva Gine, MD, PhD³, Mats Jerkeman, MD, PhD⁴, Jan Walewski, MD⁵, Martin Hutchings, MD, PhD^6*, Ulrich Mey, MD^7,8, Jon Riise, MD, PhD^9*, Marek Trneny, MD¹⁰, Vibeke K.J. Vergote^11*, Melania Celli^12*, Ofer Shpilberg, MD, MPH^13*, Maria Gomes da Silva^14*, Sirpa Leppa, MD, PhD¹⁵, Linmiao Jiang^16*, Christiane Pott^17*, Wolfram Klapper, MD^18*, Döndü Gözel^1*, Christian Schmidt, MD^1*, Michael Unterhalt, MD, PhD^1*, Marco Ladetto, MD¹⁹ and Eva Hoster^1,20*

¹Department of Internal Medicine III, LMU University Hospital Munich, Munich, Germany
²Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands
³Department of Hematology, Hospital Clinic of Barcelona, IDIBAPS, CIBERONC, GELTAMO, Barcelona, Spain
⁴Division of Oncology, Skane University Hospital and Lund University, Lund, Sweden
⁵Department of Lymphoid Malignancies, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland
⁶Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
⁷Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland
⁸Oncology and Hematology, Kantonsspital Graubünden, Chur, Switzerland
⁹Department of Oncology, Oslo University Hospital, Oslo, Norway
¹⁰First Department of Internal Medicine - Hematology, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
¹¹Department of Hematology, University Hospitals Leuven, Leuven, Belgium
¹²U.O. di Ematologia, Ospedale degli Infermi di Rimini, Rimini, Italy
¹³Institute of Hematology, Assuta Medical Centers, Tel-Aviv, Israel
¹⁴Department of Hematology, Instituto Português de Oncologia de Lisboa, Lisbon, Portugal
¹⁵Department of Oncology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
¹⁶Institute for Medical Information Processing, Biometry and Epidemiology (IBE), LMU University Munich, Munich, Germany
¹⁷Clinic for Internal Medicine II - Haematology, Oncology, University Clinic Schleswig-Holstein, Kiel, Germany
¹⁸Department of Pathology, Hematopathology Section and Lymph Node Registry, Universitätsklinikum Schleswig-Holstein, Kiel, Germany
¹⁹Department of Translational Medicine, University of Eastern Piedmont and Az Ospedaliera Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
²⁰Institute for Medical Information Processing, Biometry and Epidemiology, LMU Munich, Munich, Germany

Patrick G. Gallagher, MD

Pediatrics, Pathology, Genetics, Yale School of Medicine, Hamden, CT

Alexandra E. Preston^1*, Joe N. Frost^2*, Mohsin Badat^1*, Andrew E. Armitage^1*, Sarah Wideman^1*, Megan Teh^1*, Ruggiero Norfo^1*, Noémi Roy³, James O.J. Davies, MRCP PhD^4*, Robert Beagrie^5*, Douglas R. Higgs¹ and Hal Drakesmith^1*

¹MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
²Memorial Sloan Kettering Cancer Center, NYC
³Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
⁴MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
⁵The Wellcome Centre for Human Genetics, Oxford University, Oxford, GBR

Douglas B. Cines, MD

University of Pennsylvania PSOM, Philadelphia, PA

Catherine M. Broome, MD¹, Vickie McDonald^2*, Yoshitaka Miyakawa, MD, PhD^3*, Monica Carpenedo^4*, David J. Kuter, MD, DPhil⁵, Hanny Al-Samkari, MD⁶, James B. Bussel, MD⁷, Marie Godar^8*, Jaume Ayguasanosa^8*, Kristof De Beuf^8*, Francesco Rodeghiero, MD⁹, Marc Michel, MD^10* and Adrian C. Newland¹¹

¹Georgetown University, Washington, DC
²Barts Health NHS Trust, London, United Kingdom
³Saitama Medical University Hospital, Saitama, Japan
⁴ASST Ospedale San Gerardo di Monza, Hematology and Transplant Unit, Monza, Italy
⁵Division of Hematology Oncology, Massachusetts General Hospital, Boston, MA
⁶Massachusetts General Hospital, Boston, MA
⁷Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
⁸argenx, Ghent, Belgium
⁹Haematology Project Foundation, Affiliated to the Department of Haematology, S. Bortolo Hospital, Vicenza, Italy
¹⁰Department of Internal Medicine, National Reference Center for Immune Cytopenias, Henri Mondor University Hospital, Assistance Publique–Hôpitaux de Paris, Université Paris-Est Créteil, Créteil, France
¹¹Centre for Haematology, Barts and the London School of Medicine & Dentistry, Queen Mary University of London, London, United Kingdom

Laura C. Michaelis, MD

Division of Hematology/Oncology, Department of Medicine, The Medical College of Wisconsin Inc., Milwaukee, WI

Matthias Stelljes, Prof. Dr. med.¹, Jan Moritz Middeke, MD^2*, Gesine Bug, MD^3*, Eva-Maria Wagner, MD^4*, Lutz Peter Mueller, MD^5*, Schmid Christoph^6*, Stefan W. Krause, MD^7*, Wolfgang Bethge, MD^8*, Edgar Jost^9*, Uwe Platzbecker, MD^10*, Stefan Klein, MD¹¹, Jörg Schubert^12*, Judith Niederland^13*, Martin Kaufmann, MD¹⁴, Kerstin Schäfer-Eckart^15*, Markus Schaich, MD^16*, Henning Baldauf^17*, Friedrich Stölzel^18*, Cathleen Petzold, PhD^17*, Christoph Röllig, MD, MSC^19*, Nael Alakel, MD^20*, Björn Steffen, MD^21*, Beate Hauptrock^22*, Christian Reicherts, MD^23*, Christoph Schliemann, MD^24*, Hubert Serve, MD²¹, Alexander H. Schmidt, MD, PhD²⁵, Martin Bornhäuser, MD^26*, Jan-Henrik Mikesch, PD, MD^24* and Johannes Schetelig, MD, MSc^17,20

¹Department of Medicine / Hematology and Oncology, University of Muenster, Muenster, Germany
²Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany
³Department of Medicine II, Hematology and Oncology, University Hospital Frankfurt, Frankfurt, Germany
⁴Haematology and Oncology, University Medical Center, University Medicine Mainz, Mainz, Germany
⁵University Hospital, Martin-Luther-University Halle-Wittenberg, Halle, Germany, Halle (Saale), Germany
⁶Augsburg University Hospital and Medical Faculty, Augsburg, Germany, Augsburg, Germany
⁷University Hospital Erlangen, Germany, Erlangen, Germany
⁸Department of Hematology, Oncology, Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany
⁹University Hospital Aachen, Germany, Aachen, Germany
¹⁰Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany
¹¹Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany
¹²Elblandklinikum, Riesa, Germany, Riesa, Germany
¹³Helios Klinikum Berlin-Buch, Berlin, Germany, Berlin-Buch, Germany
¹⁴Medical Centre, Robert-Bosch-Hospital,, Stuttgart, Germany
¹⁵Department of Internal Medicine V, Nuremberg Hospital North, Paracelsus Medical University, Nuremberg, Germany
¹⁶Department of Hematology, Oncology and Palliative Care, Rems-Murr-Klinikum Winnenden, Germany, Winnenden, Germany
¹⁷Clinical Trials Unit, DKMS gGmbH, Dresden, Germany
¹⁸University Hospital, TU Dresden,Germany, Dresden, Germany
¹⁹University Hospital, TU Dresden, Germany, Dresden, Germany
²⁰University Hospital TU Dresden, Germany, Dresden, Germany
²¹Department of Hematology and Oncology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany
²²University Hospital Mainz, Germany, Mainz, Germany
²³Department of Hematology, Oncolog and Pneumology, University of Münster, Muenster, Germany
²⁴Department of Hematology, Oncolog and Pneumology, University of Münster, Münster, Germany
²⁵DKMS gGmbH, Tubingen, Germany
²⁶Department of Medicine I, University Hospital Carl Gustav Carus Dresden, Dresden, Germany

Jeffrey I. Weitz, MD, FRCPC

McMaster University, Hamilton, ON, Canada

Steven P Grover, PhD¹, Tomohiro Kawano, MD, PhD^1*, Linda Sundler Bjorkman, MD^2*, Francesco P Giorgino, BSc^3*, Sophia Dhrolia^4*, Rohan Kasthuri^3*, Sigrid Braekkan, PhD^5*, Zsofia Polai^6*, Henriette Farkas, MD, PhD^6*, Arne Egesten, MD, PhD^7*, John-Bjarne Hansen^8* and Nigel Mackman, PhD⁹

¹UNC Blood Research Center, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
²Lund University, Lund, Sweden
³Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC
⁴Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill
⁵University of Tromso, Tromso, AL, NOR
⁶Semmelweis University, Budapest, Hungary
⁷Respiratory Medicine & Allergology, Lund University, Lund, Sweden
⁸Uit - The Arctic University of Norway, Tromsø, NOR
⁹Department of Medicine, Division of Hematology, UNC Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC

Bethan Psaila, MD, PhD

Medical Research Council Weatherall Institute of Molecular Medicine and NIHR Biomedical Research Centre, University of Oxford, Oxford, United Kingdom

Edimara Reis, PhD^1*, Rebecca Buonpane^1*, Hamza Celik, PhD^1*, Caroline Marty, PhD^2*, Angela Lei^1*, Fatoumata Jobe^1*, Mark Rupar^1*, Yue Zhang^1*, Darlise DiMatteo^1*, Rahel Awdew^1*, William Vainchenker, MD, PhD^2*, Jing Zhou^1*, Ian Hitchcock, PhD³, Isabelle Plo^2*, Horacio Nastri^1* and Patrick Mayes^1*

¹Incyte Corporation, Wilmington, DE
²INSERM UMR 1287, Université Paris-Saclay, Gustave Roussy, Villejuif, France
³York Biomedical Research Institute, Department of Biology, University of York, York, United Kingdom